TG and Graves disease: In patients with Graves’ disease or hypothyroidism requiring levothyroxine, significant GLP-1RA-induced weight loss may alter thyroid hormone pharmacokinetics and necessitate medication dose adjustments [63]. Weight reduction decreases lean and fat mass, influencing thyroid hormone distribution, and may lower levothyroxine requirements [64].